414 related articles for article (PubMed ID: 18585685)
1. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.
Hagino Y; Kariura Y; Manago Y; Amano T; Wang B; Sekiguchi M; Nishikawa K; Aoki S; Wada K; Noda M
Glia; 2004 Jul; 47(1):68-77. PubMed ID: 15139014
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
[TBL] [Abstract][Full Text] [Related]
4. Subtype-specific effects of lithium on glutamate receptor function.
Karkanias NB; Papke RL
J Neurophysiol; 1999 Apr; 81(4):1506-12. PubMed ID: 10200187
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the pharmacology of GluR1 in complex with transmembrane AMPA receptor regulatory proteins gamma2, gamma3, gamma4, and gamma8.
Kott S; Sager C; Tapken D; Werner M; Hollmann M
Neuroscience; 2009 Jan; 158(1):78-88. PubMed ID: 18304748
[TBL] [Abstract][Full Text] [Related]
6. Block of kainate receptor desensitization uncovers a key trafficking checkpoint.
Priel A; Selak S; Lerma J; Stern-Bach Y
Neuron; 2006 Dec; 52(6):1037-46. PubMed ID: 17178406
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
[TBL] [Abstract][Full Text] [Related]
8. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
9. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
Partin KM; Mayer ML
Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
[TBL] [Abstract][Full Text] [Related]
10. Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.
Shen Y; Zhou Y; Yang XL
Eur J Neurosci; 1999 Dec; 11(12):4233-40. PubMed ID: 10594649
[TBL] [Abstract][Full Text] [Related]
11. Ion pore properties of ionotropic glutamate receptors are modulated by a transplanted potassium channel selectivity filter.
Hoffmann J; Gorodetskaia A; Hollmann M
Mol Cell Neurosci; 2006 Nov; 33(3):335-43. PubMed ID: 17010644
[TBL] [Abstract][Full Text] [Related]
12. Ethanol inhibits alpha-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function in central nervous system neurons by stabilizing desensitization.
Möykkynen T; Korpi ER; Lovinger DM
J Pharmacol Exp Ther; 2003 Aug; 306(2):546-55. PubMed ID: 12734392
[TBL] [Abstract][Full Text] [Related]
13. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
Partin KM; Patneau DK; Mayer ML
Mol Pharmacol; 1994 Jul; 46(1):129-38. PubMed ID: 8058047
[TBL] [Abstract][Full Text] [Related]
14. Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes.
Akinshola BE; Yasuda RP; Peoples RW; Taylor RE
Alcohol Clin Exp Res; 2003 Dec; 27(12):1876-83. PubMed ID: 14691374
[TBL] [Abstract][Full Text] [Related]
15. Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization.
Leever JD; Clark S; Weeks AM; Partin KM
Mol Pharmacol; 2003 Jul; 64(1):5-10. PubMed ID: 12815155
[TBL] [Abstract][Full Text] [Related]
16. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Li F; Owens N; Verdoorn TA
Mol Pharmacol; 1995 Jan; 47(1):148-54. PubMed ID: 7838123
[TBL] [Abstract][Full Text] [Related]
18. Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
Frølund B; Greenwood JR; Holm MM; Egebjerg J; Madsen U; Nielsen B; Bräuner-Osborne H; Stensbøl TB; Krogsgaard-Larsen P
Bioorg Med Chem; 2005 Sep; 13(18):5391-8. PubMed ID: 16043357
[TBL] [Abstract][Full Text] [Related]
19. A novel action of stargazin as an enhancer of AMPA receptor activity.
Yamazaki M; Ohno-Shosaku T; Fukaya M; Kano M; Watanabe M; Sakimura K
Neurosci Res; 2004 Dec; 50(4):369-74. PubMed ID: 15567474
[TBL] [Abstract][Full Text] [Related]
20. Modulation of AMPA receptors by a novel organic nitrate.
Toong S; Xiong ZG; Zavorin SI; Bai D; Orser BA; Thatcher GR; Reynolds JN; MacDonald JF
Can J Physiol Pharmacol; 2001 May; 79(5):422-9. PubMed ID: 11405246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
